Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

Mehta, A; Beck, M; Elliott, P; Guigliani, R; Linhart, A; Sunder-Plassmann, G; Schiffmann, R; Barbey, F; Ries, M; Clarke, JT; Fabry, Outcome survey Investigators; Huynh-Do, U (2009). Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. Lancet, 374(9706), pp. 1986-96. London: Elsevier 10.1016/S0140-6736(09)61493-8

Full text not available from this repository.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension
UniBE Contributor:	Huynh-Do, Uyen
ISSN:	0140-6736
Publisher:	Elsevier
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 15:14
Last Modified:	05 Dec 2022 14:22
Publisher DOI:	10.1016/S0140-6736(09)61493-8
Web of Science ID:	000272727000022
URI:	https://boris.unibe.ch/id/eprint/32703 (FactScience: 198006)